MEREDITH FLEMING: Open Payments
NPI 1477197085 · FORT MILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,284 in 85 payments from 18 companies in 2025. Trend: 2023 $104 · 2024 $1,184 · 2025 $2,284
Food & beverage: $2,199Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $441 |
| Janssen Biotech, Inc. | 3 | $418 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $277 |
| GENZYME CORPORATION | 12 | $263 |
| Galderma Laboratories, L.P. | 11 | $199 |
| Incyte Corporation | 2 | $104 |
| Amgen Inc. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Cipher Pharmaceuticals US LLC | 1 | $69 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, ILUMYA, Opzelura, OTEZLA.
Industry payments across SC — which companies pay providers there.
